Differences in Epstein-Barr virus (EBV) receptors expression on various human lymphoid targets and their significance to EBV-cell interaction
- PMID: 2848382
- DOI: 10.1016/0168-1702(88)90084-6
Differences in Epstein-Barr virus (EBV) receptors expression on various human lymphoid targets and their significance to EBV-cell interaction
Abstract
This study was aimed at quantitating, by means of fluorescence-activated cell sorter (FACS), EBV binding to different types of target cells, and at learning about a possible relation between EBV receptor density and the fate of cell-surface bound virus. We used fluoresceinated virus preparations of two strains of EBV (B95-8: lymphocyte transforming strain; P3HR-1: non-transforming strain) to analyze quantitatively the expression and density of EBV receptors on different human lymphoid cell lines and on B lymphocytes from both EBV-seropositive and -seronegative donors. FACS analysis was also used as a tool to approximate the cell surface area of the different lymphoid cells examined. Our results indicate that: (a) after accounting for the difference in cell surface dimensios, the fluorescence intensity of EBV-bound Raji (a B line) cells was three to four times higher per unit area than that of EBV-bound fresh B lymphocytes from an EBV-seropositive donor; (b) Molt-4 (a T line) cells bound about 21-fold less P3HR-1 EBV and 6-fold less B95-8 EBV than Raji cells per unit area; (c) B lymphocytes from EBV-seronegative adult donors bound only about one third as much virus as B cells from seropositive individuals; (d) two B lymphocyte sub-populations can be identified in the peripheral blood in regard to their ability to bind EBV, regardless of the EBV antibody status of the donor; (e) the EBV receptor on Molt-4 cells appears structurally different from the one found on Raji cells since EBV binding to Molt-4 cells was not blocked by a monoclonal antibody (OKB7) specific to the complement receptor (CR2). Further, in contrast to Raji cells, Molt-4 expressed a differential binding activity for each of the two EBV strains used. Taken together, the important differences observed in regard to EBV attachment to various targets also appear to relate to the fate of cell-surface bound virus: i.e., virus penetration might be determined, at least in part, by the density of EBV receptors on the target cell surface; thus the receptor density may play a major role in viral infection.
Similar articles
-
Epstein-Barr virus receptor expression on human CD8+ (cytotoxic/suppressor) T lymphocytes.J Gen Virol. 1990 Feb;71 ( Pt 2):379-86. doi: 10.1099/0022-1317-71-2-379. J Gen Virol. 1990. PMID: 2155291
-
Use of fluoresceinated Epstein-Barr virus to study Epstein-Barr virus-lymphoid cell interactions.J Virol. 1982 Feb;41(2):649-56. doi: 10.1128/JVI.41.2.649-656.1982. J Virol. 1982. PMID: 6281475 Free PMC article.
-
Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes.J Immunol. 1985 Nov;135(5):3068-73. J Immunol. 1985. PMID: 2995485
-
[Epstein-Barr virus penetration mechanism to T lymphoblastoid cell lines].Nihon Rinsho. 1997 Feb;55(2):404-8. Nihon Rinsho. 1997. PMID: 9046832 Review. Japanese.
-
Possible steps required in the internalization of nude Epstein-Barr virus.Cell Biol Int. 2003;27(1):61-5. doi: 10.1016/s1065-6995(02)00252-4. Cell Biol Int. 2003. PMID: 12713801 Review.
Cited by
-
Biorecognition of HPMA copolymer-adriamycin conjugates by lymphocytes mediated by synthetic receptor binding epitopes.Pharm Res. 1999 Jul;16(7):1010-9. doi: 10.1023/a:1018975414165. Pharm Res. 1999. PMID: 10450924
-
Epstein-Barr virus tissue tropism: a major determinant of immunopathogenesis.Springer Semin Immunopathol. 1991;13(2):117-31. doi: 10.1007/BF00201463. Springer Semin Immunopathol. 1991. PMID: 1664981 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources